N

Nomic

high-throughput proteomics platform employing nELISA

Manufacturing Associate 1

Full-TimePosted on 10/20/2026
No salary listed
Entry
Bachelor's
Montreal, QC, Canada
In PersonFull-time, permanent, on-site in Montreal.
Biology & BiotechBioprocess & Biomanufacturing

About the job

Requirements
  • A diploma or degree in life sciences, biotechnology, chemistry, or a related field is preferred, or equivalent relevant laboratory experience.
  • Prior hands-on wet-lab or laboratory production experience is preferred.
  • Experience working in a structured, process-driven laboratory environment is strongly preferred.
  • Experience with quality-control assays, flow cytometry, automated liquid-handling systems, or production documentation.
  • Strong attention to detail and the ability to maintain accuracy and consistency across recurring laboratory workflows.
  • Clear verbal and written communication skills, including accurate and complete documentation.
  • Strong ownership and follow-through in completing assigned work and escalating discrepancies appropriately.
Responsibilities
  • Execute core nELISA manufacturing workflows according to established procedures.
  • Independently complete assigned workflows following training and sign-off, maintaining accuracy, consistency, and attention to detail throughout each run.
  • Take ownership of assigned production activities, coordinating with Manufacturing team members to meet production timelines and communicating progress or risks promptly.
  • Execute quality-control assays and routine in-process checks according to established procedures, using flow cytometry for quality-control readouts, documenting results, and communicating unexpected observations promptly.
  • Maintain accurate material identification, traceability, and documentation throughout assigned Manufacturing workflows.
  • Complete batch manufacturing records, inventory entries, and other required production documentation accurately and promptly.
  • Rotate across multiple Manufacturing workflows to build technical breadth and provide flexible production coverage.
  • Build proficiency in laboratory information management systems (LIMS), production documentation, and automated equipment used in assigned workflows.
  • Recognize routine equipment or automation issues and perform trained checks, seeking support when needed.
  • Contribute observations and practical suggestions that improve the clarity, consistency, reliability, and scalability of Manufacturing procedures.

About the company

Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.

Company Size

51-200

Company Stage

Series B

Total Funding

$60.1M

Headquarters

Montreal, Canada

Founded

2017

Get referred to Nomic

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Nomic and Broad Clinical Labs target broader commercialization starting in early 2027.
  • June 2026 Sanger and HESI OASIS collaborations expand high-value dataset generation.
  • September 2024's $42 million Series B lifted total funding above $60 million.

What critics are saying

  • Illumina bought SomaLogic in January 2026, strengthening a much larger proteomics rival.
  • Olink and SomaLogic already own distribution, squeezing Nomic's pricing and sales cycles.
  • If pharma adoption stalls before 2027, Nomic stays a niche services business.

What makes Nomic unique

  • nELISA delivers 99.99% specificity and 0.1 pg/mL sensitivity at 1,000-plus samples daily.
  • Omni 1000 packages 1,000 curated assays with absolute quantification for discovery workflows.
  • Nature Methods publication and Nomic Portal datasets validate scalable protein profiling workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

0%

2 year growth

2%
Yahoo Finance
Sep 19th, 2024
Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

BetaKit
Mar 18th, 2020
11 Canadian companies in Y Combinator’s Winter 2020 Demo Day

This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.

TechCrunch
Mar 17th, 2020
All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Y Combinator’s Demo Day was a bit different this time around.